126 related articles for article (PubMed ID: 1386810)
1. The acute thrombogenicity of an infection-resistant rifampicin-soaked Dacron graft: an experimental study in sheep.
Lundell A; Bergqvist D; Lindblad B; Leide S
Eur J Vasc Surg; 1992 Jul; 6(4):403-7. PubMed ID: 1386810
[TBL] [Abstract][Full Text] [Related]
2. Does in situ replacement of a staphylococcal infected vascular graft with a rifampicin impregnated gelatin sealed Dacron graft reduce the incidence of subsequent infection?
Vicaretti M; Hawthorne W; Ao PY; Fletcher JP
Int Angiol; 1999 Sep; 18(3):225-32. PubMed ID: 10688422
[TBL] [Abstract][Full Text] [Related]
3. Collagen and gelatin-impregnated vascular grafts--is their thrombogenicity enhanced? An experimental study.
Jensen N; Lindblad B; Dougan P; Bergqvist D
Vasa; 1992; 21(4):365-8. PubMed ID: 1485470
[TBL] [Abstract][Full Text] [Related]
4. Does in situ replacement of a staphylococcal infected vascular graft with a rifampicin impregnated gelatin sealed Dacron graft reduce the incidence of subsequent infection?
Vicaretti M; Hawthorne W; Ao PY; Fletcher JP
Int Angiol; 2000 Jun; 19(2):158-65. PubMed ID: 10905800
[TBL] [Abstract][Full Text] [Related]
5. Prophylaxis against Staphylococcus epidermidis vascular graft infection with rifampicin-soaked, gelatin-sealed Dacron.
Sardelic F; Ao PY; Taylor DA; Fletcher JP
Cardiovasc Surg; 1996 Jun; 4(3):389-92. PubMed ID: 8782944
[TBL] [Abstract][Full Text] [Related]
6. The effect of a combined thromboxane receptor- and synthesis-antagonist on platelet, fibrinogen and leucocyte uptake in ePTFE grafts: an experimental study in sheep.
Lundell A; Bergqvist D; Leide S; Lindblad B; Ljungberg J
Eur J Vasc Surg; 1992 May; 6(3):276-81. PubMed ID: 1534299
[TBL] [Abstract][Full Text] [Related]
7. Rifampicin impregnation of a protein-sealed Dacron graft: an infection-resistant prosthetic vascular graft.
Avramovic JR; Fletcher JP
Aust N Z J Surg; 1991 Jun; 61(6):436-40. PubMed ID: 1829350
[TBL] [Abstract][Full Text] [Related]
8. An increased concentration of rifampicin bonded to gelatin-sealed Dacron reduces the incidence of subsequent graft infections following a staphylococcal challenge.
Vicaretti M; Hawthorne WJ; Ao PY; Fletcher JP
Cardiovasc Surg; 1998 Jun; 6(3):268-73. PubMed ID: 9705099
[TBL] [Abstract][Full Text] [Related]
9. Loss of seeded endothelial cells in vivo. A study of Dacron grafts under different flow conditions.
Jensen N; Linblad B; Leide S; Bergqvist D
Eur J Vasc Surg; 1994 Nov; 8(6):690-3. PubMed ID: 7828745
[TBL] [Abstract][Full Text] [Related]
10. Thrombogenicity of gelatine impregnated vascular grafts--an experimental study.
Pärsson H; Jawien A; Norgren L; Thörne J
Vasa; 1992; 21(1):6-10. PubMed ID: 1533742
[TBL] [Abstract][Full Text] [Related]
11. Effect of dextran and enoxaparin on early ePTFE graft thrombogenicity in sheep.
Matthiasson SE; Bergqvist D; Lundell A; Lindblad B
Eur J Vasc Endovasc Surg; 1995 Apr; 9(3):284-92. PubMed ID: 7542544
[TBL] [Abstract][Full Text] [Related]
12. The uptake of platelets, fibrinogen and leucocytes in ePTFE vascular grafts in relation to blood flow--an experimental study in sheep.
Lundell A; Bergqvist D; Lindblad B
Eur J Vasc Surg; 1993 Nov; 7(6):698-703. PubMed ID: 8270074
[TBL] [Abstract][Full Text] [Related]
13. Acute thrombogenicity of collagen coating of dacron grafts: an experimental study in sheep.
Konrad P; Dougan P; Bergqvist D
Eur J Vasc Surg; 1992 Jan; 6(1):67-72. PubMed ID: 1532559
[TBL] [Abstract][Full Text] [Related]
14. Treatment of vascular graft infection by in situ replacement with a rifampin-bonded gelatin-sealed Dacron graft.
Goëau-Brissonnière O; Mercier F; Nicolas MH; Bacourt F; Coggia M; Lebrault C; Pechère JC
J Vasc Surg; 1994 Apr; 19(4):739-41. PubMed ID: 8164289
[TBL] [Abstract][Full Text] [Related]
15. The influence of collagen and albumen presealants on knitted Dacron grafts.
Bearn PE; McCollum CN; Greenhalgh RM
Eur J Vasc Surg; 1993 May; 7(3):271-6. PubMed ID: 8513906
[TBL] [Abstract][Full Text] [Related]
16. Prevention of prosthetic vascular graft infection by rifampicin impregnation of a protein-sealed Dacron graft in combination with parenteral cephalosporin.
Avramovic J; Fletcher JP
J Cardiovasc Surg (Torino); 1992; 33(1):70-4. PubMed ID: 1531988
[TBL] [Abstract][Full Text] [Related]
17. The effect of a thromboxane receptor antagonist on acute ePTFE arterial graft thrombogenicity--an experimental study in sheep.
Lundell A; Bergqvist D; Leide S; Lindblad B; Ljungberg J
Eur J Vasc Surg; 1991 Jun; 5(3):321-6. PubMed ID: 1830856
[TBL] [Abstract][Full Text] [Related]
18. Thromboembolic potential of synthetic vascular grafts in baboons.
Schneider PA; Kotzé HF; Heyns AD; Hanson SR
J Vasc Surg; 1989 Jul; 10(1):75-82. PubMed ID: 2526235
[TBL] [Abstract][Full Text] [Related]
19. Experimental evaluation of small diameter synthetic arterial grafts.
Pärsson H; Jönsson BA; Norgren L; Strand SE; Thörne J
Int Angiol; 1988; 7(1):60-4. PubMed ID: 2968426
[TBL] [Abstract][Full Text] [Related]
20. Interaction between vascular prostheses and rifampicin in the prevention of the grafts infection. An experimental study.
Freyrie A; Curti T; Rodio M; Masetti L; Bignozzi L; Sanguinetti V; Joechler M; D'Addato M
Int Angiol; 1992; 11(2):113-6. PubMed ID: 1402214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]